CXCL9 and metabolic syndrome: Strikingly, GMP supplementation lowered various pro-inflammatory cytokines (i.e., MCP-1, MIG and TNFα) known to be implicated in MetS development to a level comparable to or even lower than that of chow-fed mice (Figure 2F–J).